BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27031933)

  • 1. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
    Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
    J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study.
    Tezuka Y; Omata K; Ono Y; Kambara K; Kamada H; Oguro S; Yamazaki Y; Gomez-Sanchez CE; Ito A; Sasano H; Takase K; Tanaka T; Katagiri H; Satoh F
    Hypertens Res; 2024 May; 47(5):1362-1371. PubMed ID: 38454147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
    Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
    J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
    Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
    Morimoto R; Ono Y; Tezuka Y; Kudo M; Yamamoto S; Arai T; Gomez-Sanchez CE; Sasano H; Ito S; Satoh F
    Hypertension; 2017 Aug; 70(2):334-341. PubMed ID: 28652474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
    Maiolino G; Rossitto G; Bisogni V; Cesari M; Seccia TM; Plebani M; Rossi GP;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28529209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.
    Pizzolo F; Salvagno G; Caruso B; Cocco C; Zorzi F; Zaltron C; Castagna A; Bertolone L; Morandini F; Lippi G; Olivieri O
    J Hum Hypertens; 2017 Dec; 31(12):826-830. PubMed ID: 29115296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
    Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
    Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
    Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
    Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study.
    Maiolino G; Mareso S; Bisogni V; Rossitto G; Azzolini M; Cesari M; Seccia TM; Calò L; Rossi GP
    High Blood Press Cardiovasc Prev; 2016 Mar; 23(1):19-23. PubMed ID: 26677165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
    Dorrian CA; Toole BJ; Alvarez-Madrazo S; Kelly A; Connell JM; Wallace AM
    Ann Clin Biochem; 2010 May; 47(Pt 3):195-9. PubMed ID: 20392751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
    Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
    J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading.
    Pilz S; Kienreich K; Gaksch M; Grübler M; Verheyen N; Bersuch LA; Schmid J; Drechsler C; Ritz E; Moosbrugger A; Stepan V; Pieber TR; Meinitzer A; März W; Tomaschitz A
    Horm Metab Res; 2014 Jun; 46(6):427-32. PubMed ID: 24526370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.